UNSW CRICOS Provider Code: G, TEQSA Provider ID: PRV, ABN: 57 Teaching at UNSW, Sydney NSW , Australia Telephone Footer menu UNSW School of Public Health and Community Medicine PHCM Prevention and Management of Chronic Disease. Module 1. The Chronic Care Model (CCM) was developed in the USA after an extensive review of the literature and is the most widely known model of care for people with chronic conditions [10]. The model describes the elements Vlado Perkovic is Dean of Medicine and Scientia Professor at UNSW, a Professorial Fellow at The George Institute, Australia, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications
Assessing with Role Play and Simulation | UNSW Teaching Staff Gateway
Vlado Perkovic is Dean of Medicine and Scientia Professor at UNSW, a Professorial Fellow at The George Institute, unsw medicine literature review, Australia, and a Staff Specialist in Nephrology at the Royal North Shore Hospital.
His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several major international clinical trials, and serves on the Steering Committees of several others. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management. Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training unsw medicine literature review The Royal Melbourne Hospital.
He is Chair of the International Society of Nephrology Action for Clinical Trials ISN-ACT group; and is a Fellow of the Royal Australasian College of Physicians, of the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology. Breadcrumb Home Our People. Vlado Perkovic.
publications Journal articles. Li JW; Woodward M; Perkovic V; Figtree GA; Heerspink HJL; Mahaffey KW; de Zeeuw D; Vercruysse F; Shaw W; Matthews DR; Neal B,'Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes', JACC: Heart Failureunsw medicine literature review. Neuen BL; Jardine MJ; Perkovic V, unsw medicine literature review,'Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?
Arnott C; Li Q; Kang A; Neuen BL; Bompoint S; Lam CSP; Rodgers A; Mahaffey KW; Cannon CP; Perkovic V; Jardine MJ; Neal B,'Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Journal of unsw medicine literature review American Heart Associationvol.
Neuen BL; Perkovic V,'Pilot trials in nephrology: Establishing a base for large-scale randomized trials', Journal of the American Society of Nephrologyvol. Zhou Z; Lindley RI; Rådholm K; Jenkins B; Watson J; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Shaw W; Oh R; Desai M; Matthews DR; Neal B,'Canagliflozin and Stroke in Type 2 Diabetes Mellitus', Strokevol. Cheung AK; Chang TI; Cushman WC; Furth SL; Ix JH; Pecoits-Filho R; Perkovic V; Sarnak MJ; Tobe SW; Tomson CRV; Cheung M; Wheeler DC; Winkelmayer WC; Mann JFE; Bakris GL; Damasceno A; Dwyer JP; Fried LF; Haynes R; Hirawa N; Holdaas H; Ibrahim HN; Ingelfinger JR; Iseki K; Khwaja A; Kimmel PL; Kovesdy CP; Ku E; Lerma EV; Luft FC; Lv J; McFadden CB; Muntner P; Myers MG; Navaneethan SD; Parati G; Peixoto AJ; Prasad R; Rahman M; Rocco MV; Rodrigues CIS; Roger SD; Stergiou GS; Tomlinson LA; Tonelli M; Toto RD; Tsukamoto Y; Walker R; Wang AYM; Wang J; Warady BA; Whelton PK; Williamson JD,'Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes KDIGO Controversies Conference', Kidney Internationalvol.
Unsw medicine literature review DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; Von Eynatten M; Marx N,'Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA', Circulationvol.
Thompson A; Carroll K; Inker LA; Floege J; Perkovic V; Boyer-Suavet S; Major RW; Schimpf JI; Barratt J; Cattran DC; Gillespie BS; Kausz A; Mercer AW; Reich HN; Rovin BH; West M; Nachman PH,'Proteinuria reduction as a surrogate end point in trials of IgA nephropathy', Clinical Journal of the American Society of Nephrologyvol.
Rahimi K; Canoy D; Nazarzadeh M; Salimi-Khorshidi G; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ,'Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: An overall protocol for individual patient-level data meta-analyses of over randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration BPLTTC ', BMJ Openvol.
Bello AK; Levin A; Lunney M; Osman MA; Ye F; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Davison SN; Ghnaimat M; Harden P; Htay H; Jha V; Kalantar-Zadeh K; Kerr PG; Klarenbach S; Kovesdy CP; Luyckx VA; Neuen BL; O'Donoghue D; Ossareh S; Perl J; Rashid HU; Rondeau E; See E; Saad S; Sola L; Tchokhonelidze I; Tesar V; Tungsanga K; Turan Kazancioglu R; Wang AYM; Wiebe N; Yang CW; Zemchenkov A; Zhao MH; Jager KJ; Caskey F; Perkovic V; Jindal KK; Okpechi IG; Tonelli M; Feehally J; Harris DC; Johnson DW,'Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey', The BMJvol.
Mahaffey KW; Jardine MJ; Bompoint S; Cannon CP; Neal B; Heerspink HJL; Unsw medicine literature review DM; Edwards R; Agarwal R; Bakris G; Bull S; Capuano G; De Zeeuw D; Greene T; Levin A; Pollock C; Sun T; Wheeler DC; Yavin Y; Zhang H; Zinman B; Rosenthal N; Brenner BM; Perkovic V,'Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial', Circulationvol.
Smyth B; Trongtrakul K; Haber A; Talbot B; Hawley C; Perkovic V; Woodward M; Jardine M,'Inequities in the global representation of sites participating in large, unsw medicine literature review, multicentre dialysis trials: A systematic review', BMJ Global Healthvol.
Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, unsw medicine literature review,'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', unsw medicine literature review, Diabetes, Obesity and Metabolismvol.
Smyth B; van den Broek-Best O; Hong D; Howard K; Rogers K; Zuo L; Gray NA; de Zoysa JR; Chan CT; Lin H; Zhang L; Xu J; Cass A; Gallagher M; Perkovic V; Jardine M,'Varying association of extended hours dialysis with quality of life', Clinical Journal of the American Society of Nephrologyvol.
Inker LA; Heerspink HJL; Tighiouart H; Levey AS; Coresh J; Gansevoort RT; Simon AL; Ying J; Beck GJ; Wanner C; Floege J; Li PKT; Perkovic V; Vonesh EF; Greene T, unsw medicine literature review,'GFR slope as a surrogate end point for kidney disease progression in clinical trials: A meta-analysis of treatment effects of randomized controlled trials', Journal of the American Society of Nephrologyunsw medicine literature review, vol.
Zhan Z; Smyth B; Toussaint ND; Gray NA; Zuo L; De Zoysa JR; Chan CT; Jin C; Scaria A; Hawley CM; Perkovic V; Jardine MJ; Zhang L,'Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study', BMC Nephrologyunsw medicine literature review, vol.
Cooper ME; Perkovic V; Groop PH; Hocher B; Hehnke U; Meinicke T; Koitka-Weber A; van der Walt S; von Eynatten M,'Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria', Journal of hypertensionvol, unsw medicine literature review.
Garg AX; Chan MTV; Cuerden MS; Devereaux PJ; Abbasi SH; Hildebrand A; Lamontagne F; Lamy A; Noiseux N; Parikh CR; Perkovic V; Quantz M; Rochon A; Royse A; Sessler DI; Shah PJ; Sontrop JM; Tagarakis GI; Teoh KH; Vincent J; Walsh M; Yared JP; Yusuf S; Whitlock RP,'Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: A randomized controlled trial', CMAJunsw medicine literature review, vol.
Verma S; Mazer CD; Perkovic V,'Is it time to REWIND the cardiorenal clock in diabetes? Atkins ER; Perkovic V,'Blood pressure: At what level is treatment worthwhile? Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM,unsw medicine literature review, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD?
Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Unsw medicine literature review IMPROVE-CKD study', BMJ Openvol. Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M,'Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes unsw medicine literature review Type 2 Diabetes Mellitus', Hypertension Dallas, Tex.
Figtree GA; Rådholm K; Barrett TD; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B,'Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program', Circulationvol. Jun M; Jardine MJ; Perkovic V; Pilard Q; Billot L; Rodgers A; Rogers K; Gallagher M,'Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study', PLoS ONEvol.
Jardine MJ; Li N; Ninomiya T; Feng X; Zhang J; Shi J; Zhang Y; Zhang R; Zhang J; Hao J; Perkovic V; Heerspink HL; Wu Y; Yan LL; Neal B,'Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial', Journal of Renal Nutritionvol.
Gray NA; Zuo L; Hong D; Smyth B; Jun M; De Zoysa J; Vo K; Howard K; Wang J; Lu C; Liu Z; Cass A; Perkovic V; Jardine M,'Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial', Nephrologyvol.
Rosenstock J; Perkovic V; Johansen OE; Cooper ME; Kahn SE; Marx N; Alexander JH; Pencina M; Toto RD; Wanner C; Zinman B; Woerle HJ; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; Von Eynatten M; McGuire DK,'Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults with Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial', JAMA - Journal of the American Medical Associationvol, unsw medicine literature review.
Liao JL; van den Broek-Best O; Smyth B; Hong D; Vo K; Zuo L; Gray NA; Chan CT; de Zoysa J; Perkovic V; Jiang L; Jardine M,'Effect of extended hours dialysis on sleep quality in a randomized trial', Nephrologyvol. Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW, unsw medicine literature review,'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicinevol.
Li JW; Unsw medicine literature review SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B,'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatologyvol.
Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV,'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicinevol.
Neuen BL; Young T; Heerspink HJL; Neal B; Perkovic V; Unsw medicine literature review L; Mahaffey KW; Charytan DM; Wheeler DC; Arnott C; Bompoint S; Levin A; Jardine MJ,unsw medicine literature review, 'SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis', The Lancet Diabetes and Endocrinologyvol.
Ohkuma T; Jun M; Chalmers J; Cooper ME; Hamet P; Harrap S; Zoungas S; Perkovic V; Woodward M,'Combination of changes in estimated GFR and albuminuria and the risk of major clinical outcomes', Clinical Journal of the American Society of Nephrologyvol. Smyth B; Haber A; Trongtrakul K; Hawley C; Perkovic V; Woodward M; Jardine M,'Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease: A Meta-analysis', JAMA Internal Medicinevol.
Zhou Z; Jardine M; Perkovic V; Matthews DR; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Oh R; Simpson R; Watts NB; Neal B,'Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program', Diabetologiavol.
Li J; Badve SV; Zhou Z; Oh R; Lee M; Perkovic V; De Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B,unsw medicine literature review, 'The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', DIABETESunsw medicine literature review, vol.
Jardine MJ; Mahaffey KW; Perkovic V,'Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply', The New England journal of medicinevol. Oshima M; Jun M; Ohkuma T; Toyama T; Wada T; Cooper ME; Hadjadj S; Hamet P; Harrap S; Mancia G; Marre M; Williams B; Chalmers J; Woodward M; Perkovic V,'The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON unsw medicine literature review, Diabetologiavol.
Smyth B; Krishnan AV; Gallagher M; Kiernan M; Snelling P; Hawley C; Fernando M; Hand S; Grimley K; Burman J; Heath A; Kang A; Perkovic V; Jardine MJ,'Randomised controlled trial of the impact of haemodiafiltration on uraemic neuropathy: FINESSE study protocol', BMJ Openvol. Neuen BL; Cherney DZ; Jardine MJ; Perkovic V,'Sodium-glucose cotransporter inhibitors in type 2 diabetes: Thinking beyond glucose lowering', unsw medicine literature review, CMAJvol, unsw medicine literature review.
Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Li Q; Jardine M; Oh R; Heerspink HL; Perkovic V,'Effect of canagliflozin on renal unsw medicine literature review cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program', Journal of the American Society of Nephrologyvol. Jardine MJ; Mahaffey KW; Neal B; Agarwal R; Bakris GL; Brenner BM; Bull S; Cannon CP; Charytan DM; De Zeeuw D; Edwards R; Greene T; Heerspink HJL; Levin A; Pollock C; Wheeler DC; Xie J; Zhang H; Zinman B; Desai M; Perkovic V,'The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation CREDENCE study rationale, design, and baseline characteristics', unsw medicine literature review, American Journal of Nephrologyvol, unsw medicine literature review.
Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal Unsw medicine literature review,'Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials', The Lancet Diabetes and Endocrinologyvol. de Zeeuw D; Renfurm RW; Bakris G; Rossing P; Perkovic V; Hou FF; Nangaku M; Sharma K; Heerspink HJL; Garcia-Hernandez A; Larsson TE,'Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease ALBUM : a randomised, placebo-controlled, unsw medicine literature review, phase 2 trial', The Lancet Diabetes and Endocrinologyvol.
Jun M; Ohkuma T; Zoungas S; Colagiuri S; Mancia G; Marre M; Matthews D; Poulter N; Williams B; Rodgers A; Perkovic V; Chalmers J; Woodward M,'Changes in albuminuria and the risk of major clinical outcomes in diabetes: Results from ADVANCE-ON', Diabetes Carevol.
Heerspink HJL; Perkovic V,'Trial design innovations to accelerate therapeutic advances unsw medicine literature review chronic kidney disease: Moving from single trials to an ongoing platform', Clinical Journal of the American Society of Nephrologyvol. Pecoits-Filho R; Perkovic V,'Are SGLT2 inhibitors ready for prime time for CKD?
Okpechi IG; Alrukhaimi M; Ashuntantang GE; Bellorin-Font E; Benghanem Gharbi M; Braam B; Feehally J; Harris DC; Jha V; Jindal K; Johnson DW; Unsw medicine literature review K; Kazancioglu R; Levin A; Lunney M; Olanrewaju TO; Perkovic V; Perl J; Rashid HU; Rondeau E; Salako BL; Samimi A; Sola L; Tchokhonelidze I; Wiebe N; Yang CW; Ye F; Zemchenkov A; Zhao MH; Bello AK, unsw medicine literature review,'Global capacity for clinical research in nephrology: a survey by the International Society of Nephrology', Kidney International Supplements unsw medicine literature review, vol.
Smyth B; Perkovic V,'New hypoglycemic agents and the kidney: What do the major trials tell us? Mahaffey KW; Neal B; Perkovic V; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Fabbrini E; Sun T; Li Q; Desai M; Matthews DR,'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program Unsw medicine literature review Cardiovascular Assessment Study ', Circulationvol.
Heerspink HJL; List J; Perkovic V,'New clinical trial designs for establishing drug efficacy and safety in a precision medicine era', Diabetes, Obesity and Metabolismvol. Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK,'Rationale, design, and baseline characteristics of the Unsw medicine literature review safety and Renal Microvascular outcomE study with LINAgliptin CARMELINA ® : A randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk', Cardiovascular Diabetologyvol.
Heerspink HJL; Andress DL; Bakris G; Brennan JJ; Correa-Rotter R; Dey J; Hou FF; Kitzman DW; Kohan D; Makino H; McMurray J; Perkovic V; Tobe S; Wigderson M; Parving HH; de Zeeuw D,unsw medicine literature review, 'Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan SONAR trial: A clinical trial design novel to diabetic nephropathy', Diabetes, Obesity and Metabolismvol. Mohammedi K; Chalmers J; Herrington W; Li Q; Mancia G; Marre M; Poulter N; Rodgers A; Williams B; Perkovic V; Coresh J; Woodward M,'Associations between body mass index and the risk of renal events in patients with type 2 diabetes', Nutrition and Diabetesvol.
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S,'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviewsvol.
Wong MG; Heerspink HJL; Perkovic V,'ACCORDION: Ensuring that we hear the music clearly', Clinical Journal of the American Society of Nephrologyvol. de Zeeuw D; Heerspink HJL; Jardine M; Perkovic V,'Renal trials in diabetes need a platform: time for a global approach? Heerspink HJL; Andress DL; Bakris G; Brennan JJ; Correa-Rotter R; Hou FF; Kitzman DW; Kohan D; Makino Unsw medicine literature review McMurray J; Perkovic V; Tobe S; Wigderson M; Yi T; Parving HH; de Zeeuw D, unsw medicine literature review,'Baseline characteristics and enrichment results from the SONAR trial', Diabetes, Obesity and Metabolismvol.
Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine MJ; Bakris G; Perkovic V,'Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function data unsw medicine literature review the CANVAS unsw medicine literature review, Circulationvol. Rådholm K; Figtree G; Perkovic V; Solomon SD; Mahaffey KW; De Zeeuw D; Fulcher G; Barrett TD; Shaw W; Desai M; Matthews DR; Neal B,'Canagliflozin and heart failure in type 2 diabetes mellitus: Results from the CANVAS program', Circulationvol.
Rådholm K; Wu JH; Wong MG; Foote C; Fulcher G; Mahaffey KW; Perkovic V; Neal B,'Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes — A systematic review', Diabetes Research and Clinical Practicevol.
Wong MG; Jardine M; Perkovic V,'Glucose lowering and the kidney: are all drug classes equal? Neuen BL; Perkovic V,'Reducing cardiovascular risk in people with diabetes and kidney disease', The Medical journal of Australiavol. Matthews DR; Perkovic V; Mahaffey KW,'Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist"', Circulationvol.
Neal B; Perkovic V; Matthews DR,'The authors reply', New England Journal of Medicinevol. Levin A; Tonelli M; Bonventre J; Coresh J; Donner JA; Fogo AB; Fox CS; Gansevoort RT; Heerspink HJL; Jardine M; Kasiske B; Köttgen A; Kretzler M; Levey AS; Luyckx VA; Mehta R; Moe O; Obrador G; Pannu N; Parikh CR; Perkovic V; Pollock C; Stenvinkel P; Tuttle KR; Wheeler DC; Eckardt KU; Adu D; Agarwal SK; Alrukhaimi M; Anders HJ; Ashuntantang G; Basnet S; Bello AK; Chailimpamontree W; Correa-Rotter R; Craig J; Douthat WG; Feldman HI; Ganji MR; Garcia-Garcia G; Gharbi MB; Harris DC; Jha V; Johnson DW; Kazancioglu R; Langham R; Liu ZH; Massy ZA; Nangaku M; Nelson RG; O'Donoghue D; Okpechi I; Pecoits-Filho R; Powe NR; Remuzzi G; Roberts C; Rossert J; Sola L; Stengel B; M EKS; Suzuki Y; Tanaka T; Tatiyanupanwong S; Thomas B; Uhlig K; Walker R; White SL; Wiecek A; Yang CW,'Global kidney health and beyond: a roadmap for closing gaps in care, research, and policy', The Lancetvol.
Yu J; Zhou Z; McEvoy RD; Anderson CS; Rodgers A; Perkovic V; Neal B, unsw medicine literature review,'Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: A systematic review and meta-analysis', JAMA - Journal of the American Medical Associationvol. Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D,'Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis', PLoS ONEvol.
Heerspink HJL; Makino H; Andress D; Brennan JJ; Correa-Rotter R; Coll B; Davis JW; Idler K; Kohan DE; Liu M; Perkovic V; Remuzzi G; Tobe SW; Toto R; Parving HH; de Zeeuw D,'Comparison of exposure response relationship of atrasentan between North American and Asian populations', Diabetes, Obesity and Metabolismvol. Perkovic V; Craig JC; Chailimpamontree W; Fox CS; Garcia-Garcia G; Benghanem Gharbi M; Jardine MJ; Okpechi IG; Pannu N; Stengel B; Tuttle KR; Uhlig K; Levey AS, unsw medicine literature review,'Action plan for optimizing the design of clinical trials in chronic kidney disease', Kidney International Supplementsvol.
Lv J; Zhang H; Wong MG; Jardine MJ; Hladunewich M; Jha V; Monaghan H; Zhao M; Barbour S; Reich H; Cattran D; Glassock R; Levin A; Wheeler D; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Wang HY; Perkovic V, unsw medicine literature review,'Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial', JAMA - Journal of the American Medical Associationvol.
Patel A; Pieper K; Myburgh JA; Perkovic V; Finfer S; Yang Q; Li Q; Billot L,'Reanalysis of the crystalloid versus hydroxyethyl starch trial CHEST ', New England Journal of Medicinevol. Groop PH; Cooper ME; Perkovic V; Hocher B; Kanasaki K; Haneda M; Schernthaner G; Sharma K; Stanton RC; Toto R; Cescutti J; Gordat M; Meinicke T; Koitka-Weber A; Thiemann S; von Eynatten M,'Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial', unsw medicine literature review, Diabetes, Obesity and Metabolismvol.
Neal B; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Law G; Desai M; Matthews DR,'Canagliflozin and cardiovascular and renal events in type 2 diabetes', New England Journal of Medicinevol.
Neal B; Perkovic V; Matthews DR; Mahaffey KW; Fulcher G; Meininger G; Erondu N; Desai M; Shaw W; Unsw medicine literature review F; Yee J; Deng H; de Zeeuw D,'Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study—Renal CANVAS-R : A randomized, placebo-controlled trial', Diabetes, Obesity and Metabolismvol.
Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H,'Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis', American Journal of Kidney Diseasesvol.
Marx N; McGuire DK; Perkovic V; Woerle HJ; Broedl UC; Von Eynatten M; George JT; Rosenstock J,'Composite primary end points in cardiovascular outcomes trials involving type 2 diabetes patients: Should unstable angina be included in the primary end point? Atkins ER; Hirakawa Y; Salam A; Woodward M; Cooper M; Hamet P; Harrap S; Lees K; Liu L; Mancia G; Marre M; Perkovic V; Poulter N; Williams B; Chalmers J; Rodgers A,'Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: An analysis of the PROGRESS and ADVANCEtrials', Journal of Hypertensionvol.
Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P,'Association between serum hepcidin and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrologyvol.
Jun M; James MT; Ma Z; Zhang J; Tonelli M; McAlister FA; Manns BJ; Ravani P; Quinn RR; Wiebe N; Perkovic V; Wilton SB; Winkelmayer WC; Hemmelgarn BR,'Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Unsw medicine literature review Diagnosed Atrial Fibrillation', unsw medicine literature review, American Journal of Kidney Diseasesvol, unsw medicine literature review.
Webb DJ; Coll B; Heerspink HJL; Andress D; Pritchett Y; Brennan JJ; Houser M; Correa-Rotter R; Kohan D; Makino H; Perkovic V; Remuzzi G; Tobe SW; Toto R; Busch R; Pergola P; Parving HH; de Zeeuw D,'Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, unsw medicine literature review, Placebo-Controlled Trial', Drugs in R and Dvol.
Liyanage T; Ninomiya T; Perkovic V; Woodward M; Stirnadel-Farrant H; Matsushita K; Iseki K; Seong HL; Monaghan H; Jha V,'Chronic kidney disease in Asia: Protocol for a collaborative overview', unsw medicine literature review, Nephrologyvol.
Neuen BL; Chadban SJ; Demaio AR; Johnson DW; Perkovic V,'Chronic kidney disease unsw medicine literature review the global NCDs agenda', unsw medicine literature review, BMJ Global Healthvol. Jardine MJ; Zuo L; Gray NA; De Zoysa JR; Chan CT; Gallagher MP; Monaghan H; Grieve SM; Puranik R; Lin H; Eris JM; Zhang L; Xu J; Howard K; Lo S; Cass A; Perkovic V,'A trial of extending hemodialysis hours and quality of life', unsw medicine literature review, Journal of the American Society of Nephrologyvol.
Pena MJ; de Zeeuw D; Andress D; Brennan JJ; Correa-Rotter R; Coll B; Kohan DE; Makino H; Perkovic V; Remuzzi G; Tobe SW; Toto R; Parving HH; Sharma S; Corringham T; Sharma K; Heerspink HJL,'The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy', Diabetes, Obesity and Metabolismvol. Heerspink HJL; Desai M; Jardine M; Balis D; Meininger G; Perkovic V,'Canagliflozin slows progression of renal function decline independently of glycemic effects', Journal of the American Society of Nephrologyvol.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S,'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviewsvol.
Neal B; Perkovic V; Mahaffey KW; Fulcher G; Erondu N; Desai M; Shaw W; Law G; Walton MK; Rosenthal N; de Zeeuw D; Matthews DR,'Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials', Diabetes, Obesity and Metabolismvol.
LITERATURE REVIEW: Step by step guide for writing an effective literature review
, time: 23:44Literature Reviews – The Writing Center • University of North Carolina at Chapel Hill
UNSW School of Public Health and Community Medicine PHCM Prevention and Management of Chronic Disease. Module 1. The Chronic Care Model (CCM) was developed in the USA after an extensive review of the literature and is the most widely known model of care for people with chronic conditions [10]. The model describes the elements Arc @ UNSW, is where everything outside the classroom blogger.com over student societies and clubs it’s a great place to start if you want to make new friends, learn new skills, volunteer, keep fit and more. The Arc community offers a safe and inclusive environment, celebrating the diversity of our campuses. This includes our LGBTIQ+ support and ALLY program The University of New South Wales, Medicine, Rural Clinical School, Port Macquarie Campus development process, method, writing or review of the guidelines. As the guidelines were developed in complete appraisal of all relevant literature from to the present. Methodology and tables of
No comments:
Post a Comment